New combo therapy shows promise in taming chronic hepatitis b
Disease control
Completed
This study tested a new treatment, VTP-300, combined with a low dose of nivolumab, in 121 adults with chronic hepatitis B who were already on antiviral medication. The goal was to see if the combination could further reduce hepatitis B surface antigen levels. The approach aims to…
Phase: PHASE2 • Sponsor: Barinthus Biotherapeutics • Aim: Disease control
Last updated May 07, 2026 18:43 UTC